Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Wakefulness-Promoting Agents MeSH Descriptor Data 2026


MeSH Heading
Wakefulness-Promoting Agents
Tree Number(s)
D27.505.954.427.220.612
Unique ID
D064690
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D064690
Scope Note
A specific category of drugs that prevent sleepiness by specifically targeting sleep-mechanisms in the brain. They are used to treat DISORDERS OF EXCESSIVE SOMNOLENCE such as NARCOLEPSY. Note that this drug category does not include broadly-acting central nervous system stimulants such as AMPHETAMINES.
Entry Term(s)
Eugeroic Drugs
Wake-Promoting Agents
Wake-Promoting Drug
Wake-Promoting Drugs
Wake-Promoting Substances
Registry Numbers
0
Previous Indexing
Sleep Disorders/drug therapy (2006-2013)
Public MeSH Note
2014
History Note
2014
Date Introduced
2014/01/01
Last Updated
2021/06/30
Wakefulness-Promoting Agents Preferred
page delivered in 0.134s